T6306 |
Erteberel
|
533884-09-2
|
99.87%
|
|
Erteberel (LY500307) is a potent, selective estrogen receptor β agonist with EC50 of 0.66 nM, 32-fold selectivity against estrogen receptor α. Phase 2.
|
T2146 |
Fulvestrant
|
129453-61-8
|
99.87%
|
|
Fulvestrant (ZM 182780) is an estrogen receptor (ER) antagonist (IC50=9.4 nM) and an agonist of GPR30. Fulvestrant has antitumor activity, inhibiting cell prolif...
|
T22794 |
G36
|
1392487-51-2
|
99.86%
|
|
G36 is a cell-permeable non-steroidal antagonist of GPER. G36 inhibits activation by either 17β-estradiol or the GPER-selective agonist G-1 (IC50 = 112 and 165 n...
|
T39710 |
ARV-471
|
2229711-68-4
|
99.85%
|
|
ARV-471 (Vepdegestrant) is a orally active Cereblon -based estrogen receptor (ER) PROTAC degrader. ARV-471 is developed for the research of breast cancer.
|
T15248 |
Estetrol
|
15183-37-6
|
99.83%
|
|
Estetrol(Donesta) is an orally available, selective modulator of the estrogen receptor, a naturally occurring estrogen synthesized by the human fetal liver durin...
|
T1009 |
Estrone
|
53-16-7
|
99.82%
|
|
Estrone (Aquacrine) is an aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE direct...
|
T2280 |
Endoxifen (Z-isomer)
|
112093-28-4
|
99.81%
|
|
Endoxifen Z-isomer (EDX) is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptors that also inhibits aromatase ac...
|
T3385 |
Gypenoside XVII
|
80321-69-3
|
99.76%
|
|
Gypenoside XVII (Gynosaponin S) confers protection against Aβ25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, act...
|
TN1148 |
Isopsoralenoside
|
905954-18-9
|
99.75%
|
|
Isopsoralenoside shows estrogen-like, osteoblastic proliferation accelerating, antitumor, and antibacterial effects.
|
T21387L |
Nafoxidine
|
1845-11-0
|
99.74%
|
|
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
|
TN1052 |
Lindleyin
|
59282-56-3
|
99.74%
|
|
Lindleyin is a novel phytoestrogen and might trigger many of the biological responses evoked by the physiological estrogens.
|
T0593 |
XCT790
|
725247-18-7
|
99.74%
|
|
XCT790 is a potent, selective and inverse agonist of estrogen-related receptor alpha(ERRα).
|
T6620 |
Ospemifene
|
128607-22-7
|
99.73%
|
|
Ospemifene (FC-1271a) is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symp...
|
T23540 |
Y134
|
849662-80-2
|
99.72%
|
|
Y134 is an estrogen receptor inhibitor that is selective and orally active, exhibiting strong antagonist activity against ERα and Erβ with Ki of 0.09 nM and 11....
|
T4388 |
PHTPP
|
805239-56-9
|
99.72%
|
|
PHTPP is a selective ERβ antagonist.
|
T3325 |
Liquiritigenin
|
578-86-9
|
99.7%
|
|
Liquiritigenin (4',7-Dihydroxyflavanone), a flavonoid aglycone from licorice, is a highly selective estrogen receptor β (ERβ) agonist.
|
T3840 |
Dihydroresveratrol
|
58436-28-5
|
99.68%
|
|
Dihydroresveratrol (3,4',5-Trihydroxybibenzyl) is a major metabolite of resveratrol that is produced by animal-associated bacteria, including the gut microbiota....
|
T3806 |
Kaempferide
|
491-54-3
|
99.66%
|
|
kaempferide (4'-Methylkaempferol) inhibits the proliferation of native and estrogen receptor beta overexpressing colon cancer cells through a mechanism not media...
|
T4281 |
Endoxifen
|
110025-28-0
|
99.66%
|
|
(E/Z)-Endoxifen ((E/Z)-Endoxifen) is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It ...
|
TMA1644 |
Segetalin B
|
164991-89-3
|
99.64%
|
|
Segetalin B is a natural product from Vaccaria segetalis (Neck.) Garcke, has estrogen-like activity.
|